Health policy responses to the financial crisis in Europe

Published: 2012-11-13 06:57:00

Updated: 2012-11-13 06:57:00

When confronted by an economic shock affecting the health sector in Europe, policymakers are struggling to maintain, decrease or increase current levels of public expenditure on health by adopting an alternative dispensing and prescription by generic name, according to Dr. Jaime Espin.

In an i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK